Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
about
Stress signalling pathways that impair prefrontal cortex structure and functionDevelopmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerabilityThe neurobiology of retinoic acid in affective disordersA neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.A developmental neurobiological model of motivated behavior: anatomy, connectivity and ontogeny of the triadic nodes.Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addictionDoes isotretinoin therapy of acne cure or cause depression?Methamphetamine affects cell proliferation in the medial prefrontal cortex: a new niche for toxicity.Parental education predicts corticostriatal functionality in adulthood.Phencyclidine-induced loss of asymmetric spine synapses in rodent prefrontal cortex is reversed by acute and chronic treatment with olanzapineHypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons.Neurobiological processes in adolescent addictive disorders.Affective context interferes with cognitive control in unipolar depression: an fMRI investigationLong-lasting sensitization of reward-directed behavior by amphetamine.Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.Methamphetamine self-administration and voluntary exercise have opposing effects on medial prefrontal cortex gliogenesis.The influence of leptin on the dopamine system and implications for ingestive behavior.Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.Dopamine terminals from the ventral tegmental area gate intrinsic inhibition in the prefrontal cortex.Conserved dorsal-ventral gradient of dopamine release and uptake rate in mice, rats and rhesus macaquesLoss of asymmetric spine synapses in dorsolateral prefrontal cortex of cognitively impaired phencyclidine-treated monkeys.Incidence of depression related to isotretinoin treatment in 100 acne vulgaris patients.Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.Nicotine and alcohol use in adolescent psychiatric inpatients: associations with diagnoses, psychosocial factors, gender and age.A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology.Inhibition of neuronal nitric oxide synthase prevents alterations in medial prefrontal cortex excitability induced by repeated cocaine administration.Bidirectional modulation of goal-directed actions by prefrontal cortical dopamine.Regulation of fat intake in the absence of flavour signalling.Altered structural covariance of the striatum in functional dyspepsia patients.An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.
P2860
Q24606025-FC29028F-EAB3-47AC-9750-C14641BCAF18Q24633664-A565F102-A25A-49C7-BFBA-5FDE2073D337Q24654189-A79FC9AA-A99C-4F81-9D87-600FCD81FAB5Q30465716-34E4E268-E334-4631-8C64-93E941F57552Q30483036-3DCF3D2A-45B6-4DC4-863E-93676DAAF821Q30492329-5DF08359-EF55-40E6-B844-9887FE2F42EEQ33488312-A7A616BD-961C-441C-A832-89A8F4B330CFQ33626978-5A9D2836-B5BB-4771-8673-7392EBE44613Q34365356-A47B4662-BA1F-4C98-A82C-958537FD84CBQ34617587-29AB8BF3-7890-4F1D-AE32-7A64EE440069Q34691604-BB7C297A-A135-47DB-89AC-2CB1D8018D80Q35171349-C42A4638-1BE8-4679-8865-5CDAF648A2DBQ35639591-81D5B805-0621-4E85-9B64-B93118B6F063Q36508688-5A6E84DB-92FB-4217-801E-E8E165D15C8BQ37129628-CFBDAB51-0D7C-4EB5-A259-9890CB8CC26FQ37188608-504A543A-C5CF-4B19-AE09-1EEBA3C05C69Q37252495-9157E7B7-1ADE-4D8C-9BC8-2065F377E381Q37341349-74A94A4E-7757-40E6-A5AA-9CF003550C91Q37520621-AAE71D46-206E-46BA-A315-DCE10FC25CE7Q37737291-06A01A67-2BBC-4B48-B9A8-2AF0F819C3FDQ38888717-5297AEBC-8A4B-40CF-B767-D1B3322C4B07Q41365400-281E8B91-C08B-4337-B388-E0075FF1B2CBQ42241479-C83CB021-BAEE-4775-B74D-2AC0BCE1C832Q44021194-817B1ED4-9903-4588-A2DB-A7A5C859026AQ44482372-83B41029-C8FA-4CC6-929D-05941776728BQ45186862-FB3A5D2C-A568-4D93-BEFC-E5849D7AD812Q46722153-DE5C83F4-D7FD-40A4-B656-B3EBA8E97E81Q48168253-F9F4BE06-8815-492B-8616-622B652E9C62Q48261753-8C0F29E9-E217-42B0-AB5B-2FCF6F2877F4Q48727568-35720BEA-5FF1-4051-8816-9F2876698F8CQ48763706-71E5979E-AF4D-4EA9-AF56-65C4C6D987FAQ48908840-499B2E7E-E845-428E-AAD4-4F2AC84C536C
P2860
Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Role for dopamine in the behav ...... and psychotropic drug action.
@ast
Role for dopamine in the behav ...... and psychotropic drug action.
@en
Role for dopamine in the behav ...... and psychotropic drug action.
@nl
type
label
Role for dopamine in the behav ...... and psychotropic drug action.
@ast
Role for dopamine in the behav ...... and psychotropic drug action.
@en
Role for dopamine in the behav ...... and psychotropic drug action.
@nl
prefLabel
Role for dopamine in the behav ...... and psychotropic drug action.
@ast
Role for dopamine in the behav ...... and psychotropic drug action.
@en
Role for dopamine in the behav ...... and psychotropic drug action.
@nl
P1476
Role for dopamine in the behav ...... and psychotropic drug action.
@en
P2093
P304
P356
10.1016/S0079-6123(00)26028-7
P577
2000-01-01T00:00:00Z